AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Rating of “Moderate Buy” from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has been given an average recommendation of “Moderate Buy” by the seven brokerages that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $13.60.

A number of equities analysts have commented on the company. Wall Street Zen raised AdaptHealth from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 17th. Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Canaccord Genuity Group upped their price target on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Finally, Weiss Ratings raised shares of AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, January 30th.

Insider Activity

In related news, Director David Solomon Williams III sold 5,000 shares of the firm’s stock in a transaction dated Thursday, December 4th. The stock was sold at an average price of $9.43, for a total value of $47,150.00. Following the sale, the director directly owned 45,045 shares of the company’s stock, valued at $424,774.35. This trade represents a 9.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.55% of the stock is owned by insiders.

Institutional Investors Weigh In On AdaptHealth

A number of large investors have recently made changes to their positions in the business. PNC Financial Services Group Inc. raised its holdings in shares of AdaptHealth by 22.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after acquiring an additional 1,279 shares in the last quarter. Janney Montgomery Scott LLC increased its position in AdaptHealth by 1.9% during the 2nd quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock valued at $757,000 after purchasing an additional 1,511 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in AdaptHealth by 6.6% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,095 shares of the company’s stock worth $256,000 after purchasing an additional 1,671 shares in the last quarter. CWM LLC lifted its position in shares of AdaptHealth by 17.5% in the 3rd quarter. CWM LLC now owns 12,306 shares of the company’s stock worth $110,000 after purchasing an additional 1,835 shares during the period. Finally, Arizona State Retirement System boosted its stake in shares of AdaptHealth by 9.3% during the 3rd quarter. Arizona State Retirement System now owns 27,937 shares of the company’s stock valued at $250,000 after purchasing an additional 2,367 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Stock Performance

NASDAQ AHCO opened at $10.65 on Friday. The company has a 50-day simple moving average of $10.14 and a two-hundred day simple moving average of $9.59. AdaptHealth has a 12-month low of $7.11 and a 12-month high of $11.63. The firm has a market cap of $1.44 billion, a price-to-earnings ratio of 19.36, a PEG ratio of 1.19 and a beta of 1.72. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.09.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.05). The company had revenue of $820.31 million during the quarter, compared to analysts’ expectations of $799.62 million. AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The firm’s quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.15 EPS. On average, equities analysts forecast that AdaptHealth will post 0.88 EPS for the current year.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.